Abstract:
Quercetin (Qu), is a flavonoid known to have anti-diabetic effects owing to its antioxidant property,
thus promoting regeneration of the pancreatic islets, ultimately increasing insulin secretion. But the
therapeutic application of Qu is hampered by its low oral bioavailability and its unfavourable physicochemical characteristics. The present work aimed at formulation of Quercetin loaded SoluplusVR micelles
(SMs) so as to enhance its bioavailability and provide prolonged release for the management of
diabetes. Box-Behnken response surface methodology was employed to optimize the formulation prepared using co-solvent evaporation method. Physicochemical characterization confirmed the nanospherical nature of Quercetin loaded SoluplusVR micelles (Qu-SMs) with average particle size ranging
from 85-108nm, encapsulation efficiency of 63-77%. Solid state characterization confirmed the encapsulation of Qu in the micelles without any incompatibilities. Moving forward, the results of in vitro study
revealed prolonged and slow release of Qu from the developed formulations. The in vivo pharmacokinetic study revealed improved bioavailability by enveloping the drug in SMs. Moreover, the study performed to evaluate the efficiency in diabetes treatment revealed an enhanced anti-diabetic effect.
Thus, Qu-SMs can serve as potential carriers aimed at improving the anti-diabetic property of Qu.
